Search research articles
Contact Us
Filters
Showing results (691-700 of 777) with videos related to
Page
of 78
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 9, 2026
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement
Marlene Hintersteininger, Simon Johannes Gairing, Katrin Kirsch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 30, 2022
Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS
Stefan Schwarz, Christian Lang, Matevz Harlander, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 4, 2025
The Vasopressin Biomarker Copeptin is Linked to Systemic Inflammation and Refines Prognostication in Decompensated Cirrhosis
Lukas Hartl, Marlene Hintersteininger, Benedikt Simbrunner, et al.
Hepatology (Baltimore, Md.)
|
March 6, 2024
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension
Georg Semmler, Lukas Hartl, Yuly Paulin Mendoza, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 14, 2021
The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells
Katharina A Mayer, Ursula Smole, Ci Zhu, et al.
Alimentary Pharmacology & Therapeutics
|
April 14, 2019
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort
Bernhard Scheiner, Martha M Kirstein, Florian Hucke, et al.
Hepatology (Baltimore, Md.)
|
May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease
Lukas Hartl, Katharina Haslinger, Martin Angerer, et al.
Oncotarget
|
May 21, 2017
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
Mirko Dengler, Katharina Staufer, Heidemarie Huber, et al.
Scientific Reports
|
June 21, 2018
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats
Philipp Schwabl, Ksenia Brusilovskaya, Paul Supper, et al.
JHEP Reports : Innovation in Hepatology
|
January 19, 2026
Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease
Georg Kramer, Benedikt Simbrunner, Mathias Jachs, et al.
Page
of 78
Search research articles
Search
Showing results (691-700 of 777) with videos related to
Sort By:
Page
of 78
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 9, 2026
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement
Marlene Hintersteininger, Simon Johannes Gairing, Katrin Kirsch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 30, 2022
Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS
Stefan Schwarz, Christian Lang, Matevz Harlander, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 4, 2025
The Vasopressin Biomarker Copeptin is Linked to Systemic Inflammation and Refines Prognostication in Decompensated Cirrhosis
Lukas Hartl, Marlene Hintersteininger, Benedikt Simbrunner, et al.
Hepatology (Baltimore, Md.)
|
March 6, 2024
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension
Georg Semmler, Lukas Hartl, Yuly Paulin Mendoza, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 14, 2021
The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells
Katharina A Mayer, Ursula Smole, Ci Zhu, et al.
Alimentary Pharmacology & Therapeutics
|
April 14, 2019
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort
Bernhard Scheiner, Martha M Kirstein, Florian Hucke, et al.
Hepatology (Baltimore, Md.)
|
May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease
Lukas Hartl, Katharina Haslinger, Martin Angerer, et al.
Oncotarget
|
May 21, 2017
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
Mirko Dengler, Katharina Staufer, Heidemarie Huber, et al.
Scientific Reports
|
June 21, 2018
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats
Philipp Schwabl, Ksenia Brusilovskaya, Paul Supper, et al.
JHEP Reports : Innovation in Hepatology
|
January 19, 2026
Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease
Georg Kramer, Benedikt Simbrunner, Mathias Jachs, et al.
Page
of 78